Neuronal Na 1 and K 1 channels elicit currents in opposing directions and thus have opposing effects on neuronal excitability. Mutations in genes encoding Na 1 or K 1 channels often interact genetically, leading to either phenotypic suppression or enhancement for genes with opposing or similar effects on excitability, respectively. For example, the effects of mutations in Shaker (Sh), which encodes a K 1 channel subunit, are suppressed by loss-of-function mutations in the Na 1 channel structural gene para, but enhanced by loss-of-function mutations in a second K 1 channel encoded by eag. Here we identify two novel mutations that suppress the effects of a Sh mutation on behavior and neuronal excitability. We used recombination mapping to localize both mutations to the eag locus, and we used sequence analysis to determine that both mutations are caused by a single amino acid substitution (G297E) in the S2-S3 linker of Eag. Because these novel eag mutations confer opposite phenotypes to eag loss-of-function mutations, we suggest that eag G297E causes an eag gain-of-function phenotype. We hypothesize that the G297E substitution may cause premature, prolonged, or constitutive opening of the Eag channels by favoring the ''unlocked'' state of the channel.
N EURONAL excitability, the propensity for a neuron to fire an action potential in response to synaptic activity, is regulated in large part by K 1 channels. Loss-of-function mutations in K 1 channels in vivo confer phenotypes such as prolonged nerve terminal depolarization in response to nerve stimulation and spontaneous generation of action potentials Wu et al. 1983; Warmke et al. 1991; Zhong and Wu 1991) . Whereas it has been possible to overexpress and analyze in vivo-engineered versions of channels such as EKO (White et al. 2001) , to date chromosomal K 1 channel gain-of-function mutations have been identified only in organisms in which it is difficult to perform in vivo electrophysiological studies. Consequently, such mutant channels have been best characterized following expression in heterologous systems ( Johnstone et al. 1997) . As such, the effects of such mutations on behavior and neuronal function are unclear.
The first K 1 channel gene cloned was the Drosophila Shaker (Sh) voltage-gated K 1 channel. Sh was first identified on the basis of a behavioral phenotype in which Sh mutant adults shake their legs when under etherinduced anesthesia (Kaplan and Trout 1969) . Sh mutants also exhibit increased neurotransmitter release at the Drosophila larval neuromuscular junction (nmj) ( Jan et al. 1977) and an elimination of the rapidly inactivating K 1 current I A (Wu and Haugland 1985) . The Sh gene has also recently been suggested to play a special role in controlling Drosophila sleep (Cirelli et al. 2005) .
It was found previously that combining the Sh 133 mutation with other excitability mutations can result in either the suppression or the enhancement of the Sh 133 -induced phenotypes Wu 1982, 1983; Wu et al. 1983; Stern et al. 1990) . For example, combining Sh 133 with a loss-of-function mutation in a second voltage-gated K 1 channel subunit encoded by ether-a-gogo (eag) enhances the Sh 133 -induced phenotypes . The roles played by Eag channel subunits in K 1 currents are complex: Whereas Eag subunits alone are sufficient to form functional currents, it has also been proposed that Eag can contribute to multiple K 1 currents in the larval muscle and in heterologous systems by heteromultimerization with other subunits such as Sh and slow-poke (slo) Wu 1991, 1993; Chen et al. 1996 Chen et al. , 2000 . Hence, we will refer to Eag channels. However, it is not known if Eag affects more than one current at the nmj.
Here we report the identification and characterization of two mutations (Sup 39 and Sup 146 ) that suppress the leg-shaking phenotype of Sh 133 . From recombination mapping, restriction fragment length polymorphism (RFLP) analysis, and sequencing we show that both mutations result in the same amino acid substitution 1 (G297E) in the eag-encoded channel. Therefore we have renamed these suppressor mutations eag
G297E
. We assayed synaptic transmission at the nmj in eag G297E and found that this mutation suppresses the Sh
133
-induced increase in excitatory junctional potential (ejp) and that this effect is mediated presynaptically. Furthermore, eag G297E suppresses the increased neuronal excitability conferred by the K 1 channel-blocking drugs 4-aminopyridine (4-AP) and tetraethylammonium (TEA). As the phenotypes of the Sh 133 mutation are enhanced by eag loss-of-function mutations , we hypothesize that eag G297E confers a gain-of-function phenotype. We further hypothesize that the G297E mutation might favor the unlocked state of the channel. The isolation of eag G297E provides a unique opportunity to test the phenotypes of hyperactive K 1 channels in vivo.
MATERIALS AND METHODS
Drosophila stocks: All fly stocks were maintained on standard cornmeal/agar Drosophila media at room temperature. The Sh 133 allele is a dominant Sh allele described previously (Kaplan and Trout 1969; Jan et al. 1977 ) that produces a rapid leg-shaking phenotype when under ether anesthesia. para 141 and para 63 are alleles of para previously identified and characterized as part of this mutagenesis screen and are otherwise isogenic to Sup 146 and Sup
39
, respectively (Stern et al. 1990 ). C(1)DX ywf is a compound (attached) X chromosome that will be represented as XX ywf.
Behavioral tests: Ether-induced leg shaking was assayed by exposing young adult flies to ether for 10 sec. Under these conditions, wild-type flies are immobilized except for occasional tarsal twitches; Sh
133
-mutant flies exhibit a rapid shaking of all six legs.
Mutagenesis: Sh 133 males were mutagenized by the addition of ethyl methanesulfonate (EMS) to their food according to Lewis and Bacher (1968) , except that 0.25% EMS was used. Following mutagenesis, the males were mated to an equivalent number of XX ywf females with 25 mating pairs per bottle. After 4-5 days of mating, the males were removed and discarded. EMS was inactivated as described previously (Oshima and Takano 1980) .
Mapping: The map position of Sup 39 and Sup 146 was determined by recombination mapping, first between y (1A5) and f (15F4-7), then between g (12B4-6) and sd (13F1-4), and finally between two P[ry 1 ] inserts located at 12E and 13B/C, respectively. The presence of Sup 39 and Sup 146 was scored in males by suppression of Sh
-induced leg shaking. Sequencing: All sequence analysis and alignments were produced using the BioEdit sequence alignment editor (Hall 1999) . Primer pairs flanking partial, complete, or pairs of eag exons were designed and used for PCR amplification. Sequencing was performed using the same PCR primers, or in the case of longer products, with additional internal sequencing primers. All putative mutations were resequenced at least twice from separate PCR amplifications.
Electrophysiology: Larval dissections and muscle recordings were performed as described previously ( Jan and Jan 1976; Ganetzky and Wu 1982; Stern and Ganetzky 1989; Stern et al. 1995; Huang and Stern 2002) . Ventral lateral longitidunal peripheral nerves that innervate the body-wall muscles were cut immediately posterior to the ventral ganglion and were stimulated using a suction electrode. Intracellular muscle recordings were made using a microelectrode pulled on a Flaming/Brown micropipette puller to tip resistances of 30-60 MV and filled with 3 m KCl. All dissections and recordings were performed at room temperature in standard saline solution (0.128 m NaCl, 2.0 mm KCl, 4.0 mm MgCl 2 , 0.34 m sucrose, 5.0 mm HEPES, pH 7.1, and CaCl 2 as specified in the text). Duration of the ejp was measured from half-maximal response to half-maximal response. Ventral longitudinal muscle cell 6 was used for the recording of all electrophysiological parameters. Quinidine, 4-aminopyridine, and tetraethylammonium were applied following dissection as described previously (Jan et al. 1977; Singh and Wu 1989) .
RESULTS AND DISCUSSION
Isolation of mutations that suppress the Sh leg-shaking phenotype: To identify novel mutations that suppress the leg-shaking phenotype of Sh-mutants, males carrying Sh 133 were mutagenized with EMS, as described in materials and methods, and crossed to XX ywf females, and their sons were scored for an absence of leg shaking. Of 35,000 sons tested, 9 failed to shake their legs when etherized. Five of these suppressor mutations have previously been shown to be new alleles of para, which encodes a sodium channel subunit (Stern et al. 1990 between the garnet (12B4-6) and scalloped (13F) loci and then to a region between two P[ry 1 ] elements at positions 12E and 13B/C. Finally, we used RFLP analysis to localize Sup 146 centromere-proximal to a PstI polymorphism in exon 1 of eag. The frequency of crossover between the leg-shaking suppression phenotype and the RFLP suggested that Sup 146 is 30 kb from eag exon 1, which would place it within the eag locus (see Figure 1A) . Figure 1B ). Interestingly, the eag sequence from Sup 146 flies showed the identical G297E mutation as well as two additional mutations (A1088T and I1142T). To test the possibility that these two additional mutations were generated after the mutagenesis, while the fly line was being maintained, we sequenced these regions from a second Sup 146 stock, which was split off from the first stock 6 months after Sup 146 was obtained. We found that the G297E mutation was retained in this second Sup 146 stock, but that the two additional mutations were absent. We conclude that Sup
146
, like Sup 39 , is a G297E mutation in eag; we will refer to both of them as eag
G297E
. We are not aware of any previous study that has assigned a function to G297. Previous studies have shown that eag loss-of-function mutations enhance the phenotypes of the Sh 133 mutation . In contrast, eag G297E suppresses the phenotypes of the Sh 133 mutation. We thus hypothesize that eag G297E is a gain-of-function allele (see Table 1 ).
An alignment of the Eag protein sequence from several species (Figure 2 ) indicates that position 297 and the surrounding residues are highly conserved in all members of the Eag channel subfamily, but not in the Eag-like (Elk) or Eag-related (Erg) subfamilies. Interestingly, this region of Eag is close to the site at which Mg 21 ions interact with the channel to regulate its activity, a phenomenon not seen in either the Elk or the Erg subfamilies . eag G297E suppresses the increased amount and duration of neurotransmitter release conferred by Sh
133
: In Sh 133 mutants, motor axon excitability is increased, which leads to action-potential-triggered Ca 21 influx in the nerve terminal that is larger and more prolonged than that in wild type ( Jan et al. 1977) . This increased Ca 21 influx, in turn, leads to increased neurotransmitter release from the motor neuron and subsequent muscle depolarization that is increased in amplitude and duration compared to wild type. We hypothesize that eag G297E suppresses the Sh 133 -induced leg-shaking phenotype by reducing neuronal excitability, which would compensate for the increased excitability conferred by Sh
. If so, then eag G297E might suppress the increased neurotransmitter release conferred by Sh
. To test this possibility, we used the larval nmj preparation ( Jan et al. 1977) to compare synaptic transmission at the larval nmj in eag G297E Sh 133 and eag 1 Sh 133 . With this preparation an action potential is induced in the motor axon and the consequent neurotransmitter release at the nmj elicits a depolarization in the muscle, the ejp, which is monitored with an intracellular recording electrode.
As neurotransmitter release is dependent upon Ca 21 influx into the nerve terminal, at low external [Ca 21 ] (such as 0.1 mm) at most only a single quantum of neurotransmitter is released into a wild-type neuromuscular junction following nerve stimulation. As a consequence, only failures or low amplitude ejps are observed ( Jan and Jan 1976 (Stern et al. 1990) , whereas hyperexcitable eag mutations and Dp para 1 enhance the Sh
-induced leg shaking (Stern et al. 1990) . eag G297E suppresses the Sh 133 -induced leg shaking, leading us to hypothesize that eag G297E is a gain-of-function mutation. ; Figure  3) . The smaller suppressive effect in the heterozygotes indicates that dosage of eag G297E controls the degree of suppression observed.
Similar suppression of Sh
-induced phenotypes has been observed previously by mutations in para and mle nap , which decrease the number of Na 1 channels (Ganetzky and Wu 1985; Stern et al. 1990 ) and thus create hypoexcitable neurons. These observations support our hypothesis that eag G297E reduces neuronal excitability, a phenomenon that is presumably the result of conferring a gain-of-function phenotype on the Eag channels. A suppression of Sh 133 could possibly be produced by increasing the number of Eag-containing channels in the neuronal membrane, similar to the enhancement of Sh 133 seen with Dp para 1 (Table 1 ). An alternative possibility is that this gain-of-function phenoptype is the result of premature, prolonged, or constitutive opening of the Eag channels.
When (Warmke and Ganetzky 1994) ; R-Eag1 (Ludwig et al. 1994 ), rat; B-Eag, Bos Taurus (bovine) (Frings et al. 1998) ; Ag-Eag, Anopheles gambiae (mosquito) (Mongin et al. 2004 ), H-Erg, human Eag-related gene (Warmke and Ganetzky 1994) ; Elk, human Eaglike K 1 channel (Warmke and Ganetzky 1994) . The Eag family has three branches: Eag, Erg, and Elk, all with slightly different properties. At the position indicated within the S2-S3 linker, a residue with a small, nonpolar side chain is conserved with the Eag subfamily. . This possibility is supported by the observation that mutations in human Eag can alter the binding characteristics of quinidine and other antiarrhythmic agents (Gessner et al. 2004) . Third, the K 1 channels distinct from I K in which Eag participates (I A , I CS , and I CF ; Ganetzky and Wu 1983; Wu et al. 1983; Warmke et al. 1991; Zhong and Wu 1991) are not sensitive to quinidine, and it is possible that Eag G297E exerts its effects through one of these channels. eag G297E suppresses the neuronal excitability conferred by K 1 channel-blocking drugs: The eag G297E mutation does not appear to confer any obvious behavioral abnormality in an otherwise wild-type background. No temperature-sensitive paralysis is observed, the flies appear well coordinated, and flight appears normal. To determine if eag G297E confers a defect in synaptic transmission in an otherwise wild-type background, we made measurements of ejp amplitude and duration at 0.15 mm [CaCl 2 ] . No significant decrease in either ejp amplitude or duration was observed (data not shown). Similarly, the onset rate of long-term facilitation ( Jan and Jan 1978) was also unaffected by eag G297E (data not shown). The observation that eag G297E conferred no detectable excitability phenotype in a Sh 1 background raised the possibility that the suppression of Sh 133 by eag G297E might be an allele-specific restoration of Sh function. This possibility is supported by the observation that Eag and Sh subunits can co-assemble in a channel complex (Chen et al. 1996 (Chen et al. , 2000 . To test this possibility, we examined the effects of eag G297E on the hyperexcitability conferred by two K 1 channel-blocking drugs: 4-AP, which is a specific Sh channel blocker, and TEA, which is a more general voltage-gated K 1 channel blocker Yamamoto and Suzuki 1989) .
We found that the amplitude of ejps evoked at 0.1 mm [CaCl 2 ] and 2 mm [4-AP] was significantly suppressed by eag G297E (Table 3) . Similarly, we found that large amplitude and prolonged ejps evoked at 0.1 mm [CaCl 2 ] by addition of 10 mm [TEA] were easily induced in all wildtype larvae; in contrast, in eag G297E larvae it was possible to evoke such an ejp in only about half of the larvae tested (data not shown). Furthermore, as shown in Table 3 , even when an ejp was successfully elicited, eag G297E reduced the amplitude and duration of the ejp in comparison with eag 1 . This suppression of the increased ejp conferred by 4-AP and TEA suggests that the G297E mutation increases the activity of the voltage-gated K 1 channels that remain active following the addition of 4-AP and TEA and thus that the suppression of the Sh-induced increased ejp is not allele specific. ] (0.1 mm) and 0.1 mm [quinidine] in larvae of the genotypes indicated. Values are presented as the mean 6 SEM; data were collected from at least four larvae for each genotype. *P , 0.05, ***P , 0.01 vs. eag 1 Sh
. ] (0.1 mm) and either 2 mm [4-AP] or 10 mm [TEA] in larvae of the genotypes indicated. Values are presented as the mean 6 SEM; data were collected from at least five larvae for each genotype. *P , 0.05, **P , 0.002, ***P , 0.01 vs. eag
Interestingly, it appears that eag G297E manifests its most obvious phenotypes under conditions that prolong the action potential. eag G297E acts presynaptically to reduce the ejp amplitude and duration: . Figure 4 shows that the ejc in eag G297E Sh 133 is significantly smaller than that in eag 1 Sh 133 , which is consistent with the notion that eag G297E acts presynaptically to suppress Sh 133 phenotypes by decreasing the amount of neurotransmitter released. The proportional reduction in ejc amplitude (69%) is similar to the proportional reduction in ejp amplitude (73%).
To exclude the possibility that an altered voltageindependent current or altered sensitivity to l-glutamate is responsible for the suppression of the ejp phenotypes, we compared the amplitude of spontaneous miniature ejps (mejp) (Silverman et al. 2000; Tang et al. 2000; Schö nherr et al. 2002) . Mg 21 ions slow channel activation in a concentration-and voltage-dependent manner in bovine, mouse, and Drosophila Eag (Terlau et al. 1996; Schö nherr et al. 1999; Silverman et al. 2000; Tang et al. 2000) . The observation that the G297E substitution falls within the highly conserved S2-S3 linker raised the possibility that G297E acts by eliminating or reducing the effect of (2002) suggests that Mg 21 is involved in the switch between the resting (''locked'') and activated (''unlocked'') states. We suggest that the G297E mutation alters the configuration of the channel such that it favors the ''unlocked'' over the ''locked'' state. In vitro studies of this mutant channel would be required to test this possibility.
Our results suggest that the leg-shaking and electrophysiological phenotypes caused by the Sh 133 mutation are suppressed in a dosage-dependent manner by eag
G297E
. Because phenotypes of eag G297E are opposite to those of eag loss-of-function mutants Warmke et al. 1991; Bruggemann et al. 1993) , we propose that these new mutations confer a gain-of-function phenotype to the Eag channels. Thus, eag activity regulates neuronal excitability: reduction in eag activity confers a hyperexcitable neuron, whereas increases in eag activity confer a hypoexcitabile neuron. A similar phenomenon occurs with the para-encoded Na 1 channel: decreasing or increasing channel number produces hypoexcitable or hyperexcitable neurons, respectively (Stern et al. 1990) . Given that eag G297E acts presynaptically, we hypothesize that the neuronal hypoexcitability effect is mediated by the premature, prolonged, or constitutive opening of the Eag channels in the motor neuron membrane, resulting in an attenuation of the action potential. Furthermore, our experiments raise the possibility that the reduction or elimination of the response to extracellular Mg 21 may be responsible for this gain-of-function phenotype of eag G297E .
Defects in K
1 channel function cause a wide range of diseases termed ''potassium channelopathies.'' These channelopathies encompass diseases such as episodic ataxia (D'Adamo et al. 1999) , myokymia (Dedek et al. 2001) , epilepsy (Schroeder et al. 1998) , arrhythmia (Sanguinetti 1999) , and deafness (Van Hauwe et al. 2000) . Furthermore, loss of normal K 1 channel function can enhance tumor growth (Meyer and Heinemann 1998; Meyer et al. 1999; Pardo et al. 1999; Smith et al. 2002; Suzuki and Takimoto 2004) . K 1 channel gainof-function mutations have been identified in patients with diseases such as familial atrial fibrillation (Chen et al. 2003) and have also been associated with the low prevalence of diseases such as diastolic hypertension in some populations (Fernandez-Fernandez et al. 2004) . Polymorphisms such as eag G297E , if they exist in humans, might be of particular therapeutic importance because an individual carrying such a polymorphism might exhibit no overt abnormalities and yet show an aberrant sensitivity to particular therapeutic drugs. Consequently, understanding how K 1 channels function, how they are regulated, and how they interact with other membrane components is of substantial importance. The identification of a gain-of-function mutation in a K 1 channel gene that can be studied further both in vivo and in vitro provides a unique opportunity to obtain new knowledge of K 1 channel regulation.
